VEC.L Share News (VEC)
VEC Share
VEC Share
VEC Share
VEC Share
VEC
VEC Share
VEC Broker
VEC Directors
VEC Financial
VEC
VEC Short
VECThu, 21st May 2015 13:01
(Sharecast News) - Hikma Pharmaceuticals shares rallied after the company said it had received approval from the US Food and Drug Administration and launched its generic version of GlaxoSmithKline's asthma treatment, Advair Diskus.
Read more
Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus
Read moreIN BRIEF: Tissue Regenix Adds Former Vectura COO To Board
Read moreVectura Inks Agreement To Support Kinaset Therapeutics For Asthma Drug
Read more(Sharecast News) - Vectura has signed a global licence and development deal with Kinaset Therapeutics of the US for the development and commercialisation of the VR588 pan-JAK asthma treatment.
Read more(Sharecast News) - Inhalation-focussed contract design and manufacture organisation Vectura Group announced on Friday that the United States Court of Appeals for the Federal Circuit has denied GlaxoSmithKline's (GSK) motions for judgment as a matter of law, a new trial on infringement, and for a new trial on damages in litigation concerning Vectura's US patent 8303991.
Read moreIN BRIEF: Vectura Notes US Court Denying GSK's Motions For New Trials
Read moreUK EXECUTIVE CHANGE SUMMARY: Tracsis Appoints New Finance Chief
Read moreIN BRIEF: Vectura Notes Hikma's Advair US Regulatory Setback
Read moreVectura Revenue Slips But Swings To First Half Profit
Read moreUK TRADING UPDATE SUMMARY: Henry Boot Unit In Voluntary Liquidation
Read moreTOP NEWS: ITV Bumped From FTSE 100 For B&M European Value Retail
Read moreUK TRADING UPDATE SUMMARY: Retailer Sosandar In Quarterly Revenue Jump
Read moreDIRECTOR DEALINGS: Vectura Group Non-Exec Matthews Buys First Shares
Read moreVectura Inks Deal With Aerami To Develop Inhaled Imatinib
Read more